Article
Phenotype-dependent effects of IL-17A inhibitors on lipid profiles in moderate-to-severe plaque psoriasis: a retrospective cohort study.
Lipids in health and disease - 9 May 2026
Wu Chao, Wang Si-Fan, Li Dian-Mo, He Chun-Xia, Jin Hong-Zhong
Abstract excerpt
BACKGROUND: Psoriasis is associated with elevated cardiovascular risk, partly mediated through dyslipidemia and the interleukin-23/Th17 inflammatory axis. Interleukin-17A (IL-17A) inhibitors demonstrate superior dermatologic efficacy, but their effects on lipid metabolism remain controversial. Most previous studies analyzed lipid changes at the population level without stratifying by baseline lipid phenotypes....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
